There are thousands of publications each year, but the American Heart Association (AHA) publication stands out – it is special – a landmark article. The AHA has made a bold move in highlighting and sticking to the science when it comes to protecting the heart from marijuana.
Robert Lee Page II, PharmD, MSPH
Robert Page is a Professor in the Departments of Clinical Pharmacy and Physical/Rehabilitative Medicine at the University of Colorado Denver, Schools of Pharmacy and Medicine (Aurora), and the clinical pharmacy specialist for the Division of Cardiology Section of Advanced Heart Failure and Heart Transplantation. He is also the Clinical Lead for the Colorado Evidenced Based Drug Utilization Program.
Dr. Page received his bachelor’s of science degree in biology and chemistry from Furman University (Greenville, SC); bachelor’s of science in pharmacy and Pharm.D. degrees from the Medical University of South Carolina (MUSC; Charleston); Masters of Science in Public Health with an epidemiology focus from the University of Colorado School of Medicine (Denver); and specialty residency in pharmacotherapy with a focus in cardiology from MUSC. He is a board-certified pharmacotherapy specialist with added qualifications in cardiology, a Board Certified Geriatric Pharmacist, and a Fellow of the following organizations: the Heart Failure Society of America, the American College of Clinical Pharmacy, the American Heart Association (Council on Clinical Cardiology), the American Society of Consultant Pharmacists, and the American Society of Health-System Pharmacists. Dr Page has served on numerous AHA, HFSA, and ACC committees and is past chair of the Clinical Pharmacology Subcommittee of the Council on Clinical Cardiology, and has been an external reviewer for several ACCF/AHA cardiovascular management guidelines. Dr. Page has 20 years of clinical expertise in the management of patients with heart failure in both the outpatient and inpatient setting. He has published over 200 peer reviewed manuscripts, abstracts, and book chapters in the management of patients with cardiovascular disease.
Can the public health solution to drug overdoses follow the public health model for COVID?Can we do contact tracing for overdoses like we do...
Is you had Glaucoma, a disease that can make you blind, would you trust eye drops from a pharmacy or marijuana? Would you want...
If Illicit Fentanyl as Weapon of Mass Destruction? Who better to ask than former Assistant Secretary of Defense, the Honorable Andrew Weber. Andy talks...